Global Robotic IV Compounding System 麻豆原创 Research Report 2024

Publication ID:

PB510240301

Publication Date:

October 17, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

A Robotic IV Compounding System is an automated technology designed to prepare intravenous medications with high precision and safety. These systems streamline the compounding process by integrating robotics, software, and sterile environments to minimize human error and contamination risks. The robotic arm accurately measures and combines ingredients, while advanced sensors ensure the correct dosages and formulations. This technology enhances efficiency in pharmacies and hospitals, allowing for faster medication preparation and improving overall patient safety. Additionally, it helps in complying with regulatory standards by maintaining consistent quality and documentation throughout the compounding process.
The global Robotic IV Compounding System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Robotic IV Compounding System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Robotic IV Compounding System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Robotic IV Compounding System include Arxium, Omnicell, Grifols, Weibond Technology, General Healthy, Lachsis, Shenzhen Broadcare Robots, Sanggu, NewIcon, Comecer, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Robotic IV Compounding System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Robotic IV Compounding System.
The Robotic IV Compounding System market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Robotic IV Compounding System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Robotic IV Compounding System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Arxium
Omnicell
Grifols
Weibond Technology
General Healthy
Lachsis
Shenzhen Broadcare Robots
Sanggu
NewIcon
Comecer
ICU Medical
Kapsam Health Products
Steriline
Baxter
Segment by Type
Closed System
Non-closed System
Segment by Application
Hazardous Drugs
Non-hazardous Drugs
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Robotic IV Compounding System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Robotic IV Compounding System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Robotic IV Compounding System 麻豆原创 Overview
1.1 Product Definition
1.2 Robotic IV Compounding System by Type
1.2.1 Global Robotic IV Compounding System 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Closed System
1.2.3 Non-closed System
1.3 Robotic IV Compounding System by Application
1.3.1 Global Robotic IV Compounding System 麻豆原创 Value by Application (2024-2030)
1.3.2 Hazardous Drugs
1.3.3 Non-hazardous Drugs
1.4 Global Robotic IV Compounding System 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Robotic IV Compounding System Revenue 2019-2030
1.4.2 Global Robotic IV Compounding System Sales 2019-2030
1.4.3 Global Robotic IV Compounding System 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Robotic IV Compounding System 麻豆原创 Competition by Manufacturers
2.1 Global Robotic IV Compounding System Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Robotic IV Compounding System Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Robotic IV Compounding System Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Robotic IV Compounding System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Robotic IV Compounding System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Robotic IV Compounding System, Product Type & Application
2.7 Global Key Manufacturers of Robotic IV Compounding System, Date of Enter into This Industry
2.8 Global Robotic IV Compounding System 麻豆原创 Competitive Situation and Trends
2.8.1 Global Robotic IV Compounding System 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Robotic IV Compounding System Players 麻豆原创 Share by Revenue
2.8.3 Global Robotic IV Compounding System 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Robotic IV Compounding System 麻豆原创 Scenario by Region
3.1 Global Robotic IV Compounding System 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Robotic IV Compounding System Sales by Region: 2019-2030
3.2.1 Global Robotic IV Compounding System Sales by Region: 2019-2024
3.2.2 Global Robotic IV Compounding System Sales by Region: 2025-2030
3.3 Global Robotic IV Compounding System Revenue by Region: 2019-2030
3.3.1 Global Robotic IV Compounding System Revenue by Region: 2019-2024
3.3.2 Global Robotic IV Compounding System Revenue by Region: 2025-2030
3.4 North America Robotic IV Compounding System 麻豆原创 Facts & Figures by Country
3.4.1 North America Robotic IV Compounding System 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Robotic IV Compounding System Sales by Country (2019-2030)
3.4.3 North America Robotic IV Compounding System Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Robotic IV Compounding System 麻豆原创 Facts & Figures by Country
3.5.1 Europe Robotic IV Compounding System 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Robotic IV Compounding System Sales by Country (2019-2030)
3.5.3 Europe Robotic IV Compounding System Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Robotic IV Compounding System 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Robotic IV Compounding System 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Robotic IV Compounding System Sales by Region (2019-2030)
3.6.3 Asia Pacific Robotic IV Compounding System Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Robotic IV Compounding System 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Robotic IV Compounding System 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Robotic IV Compounding System Sales by Country (2019-2030)
3.7.3 Latin America Robotic IV Compounding System Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Robotic IV Compounding System 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Robotic IV Compounding System 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Robotic IV Compounding System Sales by Country (2019-2030)
3.8.3 Middle East and Africa Robotic IV Compounding System Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Robotic IV Compounding System Sales by Type (2019-2030)
4.1.1 Global Robotic IV Compounding System Sales by Type (2019-2024)
4.1.2 Global Robotic IV Compounding System Sales by Type (2025-2030)
4.1.3 Global Robotic IV Compounding System Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Robotic IV Compounding System Revenue by Type (2019-2030)
4.2.1 Global Robotic IV Compounding System Revenue by Type (2019-2024)
4.2.2 Global Robotic IV Compounding System Revenue by Type (2025-2030)
4.2.3 Global Robotic IV Compounding System Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Robotic IV Compounding System Price by Type (2019-2030)
5 Segment by Application
5.1 Global Robotic IV Compounding System Sales by Application (2019-2030)
5.1.1 Global Robotic IV Compounding System Sales by Application (2019-2024)
5.1.2 Global Robotic IV Compounding System Sales by Application (2025-2030)
5.1.3 Global Robotic IV Compounding System Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Robotic IV Compounding System Revenue by Application (2019-2030)
5.2.1 Global Robotic IV Compounding System Revenue by Application (2019-2024)
5.2.2 Global Robotic IV Compounding System Revenue by Application (2025-2030)
5.2.3 Global Robotic IV Compounding System Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Robotic IV Compounding System Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Arxium
6.1.1 Arxium Company Information
6.1.2 Arxium Description and Business Overview
6.1.3 Arxium Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Arxium Robotic IV Compounding System Product Portfolio
6.1.5 Arxium Recent Developments/Updates
6.2 Omnicell
6.2.1 Omnicell Company Information
6.2.2 Omnicell Description and Business Overview
6.2.3 Omnicell Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Omnicell Robotic IV Compounding System Product Portfolio
6.2.5 Omnicell Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Company Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Robotic IV Compounding System Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Weibond Technology
6.4.1 Weibond Technology Company Information
6.4.2 Weibond Technology Description and Business Overview
6.4.3 Weibond Technology Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Weibond Technology Robotic IV Compounding System Product Portfolio
6.4.5 Weibond Technology Recent Developments/Updates
6.5 General Healthy
6.5.1 General Healthy Company Information
6.5.2 General Healthy Description and Business Overview
6.5.3 General Healthy Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.5.4 General Healthy Robotic IV Compounding System Product Portfolio
6.5.5 General Healthy Recent Developments/Updates
6.6 Lachsis
6.6.1 Lachsis Company Information
6.6.2 Lachsis Description and Business Overview
6.6.3 Lachsis Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lachsis Robotic IV Compounding System Product Portfolio
6.6.5 Lachsis Recent Developments/Updates
6.7 Shenzhen Broadcare Robots
6.7.1 Shenzhen Broadcare Robots Company Information
6.7.2 Shenzhen Broadcare Robots Description and Business Overview
6.7.3 Shenzhen Broadcare Robots Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Shenzhen Broadcare Robots Robotic IV Compounding System Product Portfolio
6.7.5 Shenzhen Broadcare Robots Recent Developments/Updates
6.8 Sanggu
6.8.1 Sanggu Company Information
6.8.2 Sanggu Description and Business Overview
6.8.3 Sanggu Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanggu Robotic IV Compounding System Product Portfolio
6.8.5 Sanggu Recent Developments/Updates
6.9 NewIcon
6.9.1 NewIcon Company Information
6.9.2 NewIcon Description and Business Overview
6.9.3 NewIcon Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.9.4 NewIcon Robotic IV Compounding System Product Portfolio
6.9.5 NewIcon Recent Developments/Updates
6.10 Comecer
6.10.1 Comecer Company Information
6.10.2 Comecer Description and Business Overview
6.10.3 Comecer Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Comecer Robotic IV Compounding System Product Portfolio
6.10.5 Comecer Recent Developments/Updates
6.11 ICU Medical
6.11.1 ICU Medical Company Information
6.11.2 ICU Medical Description and Business Overview
6.11.3 ICU Medical Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.11.4 ICU Medical Robotic IV Compounding System Product Portfolio
6.11.5 ICU Medical Recent Developments/Updates
6.12 Kapsam Health Products
6.12.1 Kapsam Health Products Company Information
6.12.2 Kapsam Health Products Description and Business Overview
6.12.3 Kapsam Health Products Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Kapsam Health Products Robotic IV Compounding System Product Portfolio
6.12.5 Kapsam Health Products Recent Developments/Updates
6.13 Steriline
6.13.1 Steriline Company Information
6.13.2 Steriline Description and Business Overview
6.13.3 Steriline Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Steriline Robotic IV Compounding System Product Portfolio
6.13.5 Steriline Recent Developments/Updates
6.14 Baxter
6.14.1 Baxter Company Information
6.14.2 Baxter Description and Business Overview
6.14.3 Baxter Robotic IV Compounding System Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Baxter Robotic IV Compounding System Product Portfolio
6.14.5 Baxter Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Robotic IV Compounding System Industry Chain Analysis
7.2 Robotic IV Compounding System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Robotic IV Compounding System Production Mode & Process
7.4 Robotic IV Compounding System Sales and 麻豆原创ing
7.4.1 Robotic IV Compounding System Sales Channels
7.4.2 Robotic IV Compounding System Distributors
7.5 Robotic IV Compounding System Customers
8 Robotic IV Compounding System 麻豆原创 Dynamics
8.1 Robotic IV Compounding System Industry Trends
8.2 Robotic IV Compounding System 麻豆原创 Drivers
8.3 Robotic IV Compounding System 麻豆原创 Challenges
8.4 Robotic IV Compounding System 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Arxium
Omnicell
Grifols
Weibond Technology
General Healthy
Lachsis
Shenzhen Broadcare Robots
Sanggu
NewIcon
Comecer
ICU Medical
Kapsam Health Products
Steriline
Baxter

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.